Cyberonics Inc. (NASDAQ:CYBX): According to Jefferies, there is a 50 percent probability that CMS will reverse its non-coverage decision regarding Cyberonics’ depression treatment. The firm believes that Cyberonics will file a formal request to Medicare asking for an overturn of the agencies non-coverage policy for VNS in depression in the company months, and claims that depression is worth $15 per share of Cyberonic. The firm maintains its Buy rating but increases its price target on the stock.
Cameron International Corporation’s (NYSE:CAM) Q2 EPS should surpass the consensus estimate, according to RBC’s expectations, and the firm predicts an increase in the company’s margins. The firm keeps a Top Pick rating and a $54 price target on the stock.
Total SA (NYSE:TOT) has been named a short Research Tactical Idea by Morgan Stanley
Royal Dutch Shell (NYSE:RDS.A) was named a long Research Tactical Idea by Morgan Stanley.
CMS Energy Corp. (NYSE:CMS): Following conversations with CMS management, BMO Capital has concluded that the benefits from the company’s favorable Q2 weather as well as cost-cutting initiatives are underestimated by the Street. The firm predicts that the company can gain a 5 percent to 7 percent EPS growth over the next few years. The firm keeps its Outperform rating on the stock.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.